ADD/ADHD is a complicated diagnosis, usually involving difficult-to-measure symptoms like hyperactivity and distractibility. These conditions have most often been treated with stimulants, such as Adderall and Ritalin, which can be effective, but also come with certain negative side effects.
The reason for this is the way cannabinoids interact with the brain, potentially helping people with dopamine deficiencies, which has been linked to ADHD. It's also possible that people who have trouble focusing benefit from the way cannabis can slow down the mind for some. This would help explain why cannabis is popular with ADHD sufferers.
A more recent German study indicated there are focus and concentration benefits with low doses of high-CBD strains. This study ultimately concluded "For adult patients with ADHD, who experience side effects or do not profit from standard medication, cannabis may be an effective and well-tolerated alternative."
Many sufferers have a long, self-reported history of self-medication with cannabis with success. Recent studies indicate there may be therapeutic value for some of the 5% of adults with ADD or ADHD.
A 2013 study indicated CBD can induce anticompulsive-like effects in people with obsessive compulsive disorder. Like the ADHD research, this area still needs more exploration, but early results are positive.
People who suffer from severe post-traumatic stress experience anxiety and nightmares. Cannabis can reduce REM sleep resulting in fewer, less vivid dreams.
With certain cannabis strains people may find the psychoactive effects calming and relaxing. Some studies have shown that using only CBD in oil or capsule form can reduce everyday feelings of anxiety for extended periods, while low-temperature vaporizing with CBD-rich cannabis can relieve panic attacks in a few short minutes.
Peter Strohbeck-Kuehner, Gisela Skopp and Rainer Mattern
Archiv für Kriminologie, 2008Source
Ake T. Lu, Matthew N. Ogdie, Marjo-Ritta Järvelin, Irma K. Moilanen, Sandra K. Loo, James T. McCracken, James J. McGough, May H. Yang, Leena Peltonen, Stanley F. Nelson, Rita M. Cantor and Susan L. Smalley
American Journal of Medical Genetics, 2008Source
Pablo Pandolfo, Leandro F. Vendruscolo, Regina Sordi and Reinaldo N. Takahashi
Eva Milz and Franjo Grotenhermen
Medical Practice for Psychiatry and Psychotherapy, 2016Source
Mirella Nardo, Plinio C. Casarotto, Felipe V. Gomes and Francisco S. Guimaraes
Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2013Source
Thomas Schierenbeck, Dieter Riemann, Mathias Berger and Magdolna Hornyak
Sleep Medicine Reviews, 2008Source
Emma Childs, Joseph A. Lutz and Harriet de Wit
Drug and Alcohol Dependence, 2017Source
Esther Blessing, Maria Steenkamp, Jorge Manzanares and Charles Marmar
Neurotherapeutics: The Journal of the American Society for Experimental Neurotherapeutics, 2015Source